• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sofosbuvir and Simeprevir Treatment of a Stem Cell Transplanted Teenager With Chronic Hepatitis C Infection.

作者信息

Fischler Björn, Priftakis Peter, Sundin Mikael

机构信息

From the *Division of Pediatrics, CLINTEC, Karolinska Institutet; and †Department of Pediatrics, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Pediatr Infect Dis J. 2016 Jun;35(6):708-10. doi: 10.1097/INF.0000000000001122.

DOI:10.1097/INF.0000000000001122
PMID:26928522
Abstract

There have been no previous reports on the use of interferon-free combinations in pediatric patients with chronic hepatitis C infection. An infected adolescent with severe sickle cell disease underwent stem cell transplantation and subsequent treatment with sofosbuvir and simeprevir during ongoing immunosuppression. Despite the emergence of peripheral edema as a side effect, treatment was continued with sustained antiviral response.

摘要

相似文献

1
Sofosbuvir and Simeprevir Treatment of a Stem Cell Transplanted Teenager With Chronic Hepatitis C Infection.
Pediatr Infect Dis J. 2016 Jun;35(6):708-10. doi: 10.1097/INF.0000000000001122.
2
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study.索磷布韦和西美瑞韦联合利巴韦林治疗合并或不合并 HIV 感染的 HCV 感染患者 12 周的安全性和有效性:一项多中心观察性研究。
Int J Antimicrob Agents. 2017 Mar;49(3):296-301. doi: 10.1016/j.ijantimicag.2016.11.030. Epub 2017 Feb 2.
3
Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on haemodialysis or GFR <30 ml/min.索磷布韦和西米普明用于丙型肝炎基因1型患者——接受血液透析或肾小球滤过率<30 ml/分钟的终末期肾病患者。
Liver Int. 2016 Jun;36(6):798-801. doi: 10.1111/liv.13025. Epub 2015 Dec 15.
4
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver disease.西米普明、达卡他韦和索非布韦用于治疗失代偿期肝病的丙型肝炎病毒感染患者。
J Viral Hepat. 2017 Apr;24(4):287-294. doi: 10.1111/jvh.12645. Epub 2016 Nov 23.
5
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.在患有严重复发性丙型肝炎感染的肝移植受者中,将达卡他韦与索磷布韦或simeprevir联合使用。
Liver Transpl. 2016 Apr;22(4):446-58. doi: 10.1002/lt.24416.
6
Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience.基于索磷布韦的慢性丙型肝炎患者治疗中与利巴韦林相关的不良事件:社区实践经验
J Dig Dis. 2016 Feb;17(2):113-21. doi: 10.1111/1751-2980.12313.
7
Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.索磷布韦和西米普明对肝移植受者复发性丙型肝炎有效。
Liver Int. 2015 Nov;35(11):2442-7. doi: 10.1111/liv.12856. Epub 2015 May 12.
8
Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient.肝移植受者新型丙型肝炎抗病毒治疗后发生严重肺部毒性
Mayo Clin Proc. 2015 Sep;90(9):1294-7. doi: 10.1016/j.mayocp.2015.06.015. Epub 2015 Jul 29.
9
Simeprevir and sofosbuvir for treatment of chronic hepatitis C infection.西米普明和索非布韦用于治疗慢性丙型肝炎感染。
Clin Ther. 2015 Feb 1;37(2):243-67. doi: 10.1016/j.clinthera.2014.12.012. Epub 2015 Jan 16.
10
Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir.癫痫发作作为simeprevir和索磷布韦治疗的潜在并发症。
Am J Ther. 2016 Mar-Apr;23(2):e570-1. doi: 10.1097/MJT.0000000000000188.

引用本文的文献

1
Breakthroughs and challenges in the management of pediatric viral hepatitis.儿科病毒性肝炎管理的突破与挑战。
World J Gastroenterol. 2021 May 28;27(20):2474-2494. doi: 10.3748/wjg.v27.i20.2474.
2
The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C.直接作用抗病毒药物在儿童慢性丙型肝炎治疗中的作用
J Clin Transl Hepatol. 2017 Mar 28;5(1):59-66. doi: 10.14218/JCTH.2016.00053. Epub 2017 Feb 7.